{"id":35990,"date":"2025-02-18T23:37:32","date_gmt":"2025-02-18T23:37:32","guid":{"rendered":"https:\/\/beyondtype1.org\/la-fda-aprueba-merilog-una-nueva-opcion-de-insulina-de-accion-rapida\/"},"modified":"2025-02-18T23:39:57","modified_gmt":"2025-02-18T23:39:57","slug":"fda-aprueba-merilog-insulina-de-accion-rapida","status":"publish","type":"resources","link":"https:\/\/beyondtype1.org\/es\/fda-aprueba-merilog-insulina-de-accion-rapida\/","title":{"rendered":"La FDA aprueba Merilog: una nueva opci\u00f3n de insulina de acci\u00f3n r\u00e1pida"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">La Administraci&oacute;n de Alimentos y Medicamentos de los Estados Unidos (<\/span><i><span style=\"font-weight: 400;\">FDA<\/span><\/i><span style=\"font-weight: 400;\">) <\/span><a href=\"https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-rapid-acting-insulin-biosimilar-product-treatment-diabetes\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">ha aprobado Merilog <\/span><\/a><span style=\"font-weight: 400;\">(<\/span><i><span style=\"font-weight: 400;\">insulina-aspart-szjj<\/span><\/i><span style=\"font-weight: 400;\">), a <\/span><a href=\"https:\/\/beyondtype1.org\/es\/que-es-la-insulina-biosimilar\/\"><span style=\"font-weight: 400;\">biosimilar<\/span><\/a><span style=\"font-weight: 400;\"> a Novolog (<\/span><i><span style=\"font-weight: 400;\">insulina aspart<\/span><\/i><span style=\"font-weight: 400;\">). <\/span><\/p>\n<p><span style=\"font-weight: 400;\">Esto significa que ahora tienes otra<\/span> opci&oacute;n <a href=\"https:\/\/beyondtype1.org\/es\/todo-sobre-la-insulina\/\"><span style=\"font-weight: 400;\">de insulina<\/span><\/a> de acci&oacute;n r&aacute;pida <span style=\"font-weight: 400;\">para ayudarte a mantener tus niveles de glucosa en sangre bajo control a la hora de comer.<\/span><\/p>\n<h3><b>&iquest;Qu&eacute; es Merilog?<\/b><\/h3>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Merilog es una insulina de acci&oacute;n r&aacute;pida dise&ntilde;ada para reducir<\/span> <a href=\"https:\/\/beyondtype1.org\/es\/fomas-manejar-picos-glucosa-insulina-rapida\/\"><span style=\"font-weight: 400;\">los picos de glucosa en sangre<\/span><\/a> <span style=\"font-weight: 400;\">despu&eacute;s de comer.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Funciona igual que<\/span> <a href=\"https:\/\/www.novolog.com\/taking-novolog.html\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">Novolog<\/span><\/a> <span style=\"font-weight: 400;\">y se toma justo antes de las comidas (<\/span> <i><span style=\"font-weight: 400;\">5 a 10 minutos antes<\/span><\/i> <span style=\"font-weight: 400;\">).<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Estar&aacute; disponible en dos formatos:<\/span>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Pluma precargada de 3 ml (<\/span> <i><span style=\"font-weight: 400;\">para un solo uso<\/span><\/i> <span style=\"font-weight: 400;\">)<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Vial de 10 ml (<\/span> <i><span style=\"font-weight: 400;\">para dosis m&uacute;ltiples<\/span><\/i> <span style=\"font-weight: 400;\">)<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h3><b>&iquest;Por qu&eacute; es esto tan importante?<\/b><\/h3>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>M&aacute;s opciones de insulina<\/b> <span style=\"font-weight: 400;\">para personas con diabetes.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Los biosimilares suelen ser m&aacute;s asequibles<\/b> <span style=\"font-weight: 400;\">, lo que hace que la insulina sea m&aacute;s accesible.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>La misma seguridad y eficacia<\/b> <span style=\"font-weight: 400;\">que Novolog.<\/span><\/li>\n<\/ul>\n<h3><b>&iquest;Qui&eacute;n puede utilizar Merilog?<\/b><\/h3>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Adultos y ni&ntilde;os<\/b> <span style=\"font-weight: 400;\">con diabetes que necesitan insulina de acci&oacute;n r&aacute;pida.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Cualquier persona que ya est&eacute; usando Novolog puede cambiar de medicamento con la aprobaci&oacute;n de su m&eacute;dico. Esto puede resultar &uacute;til si su plan de seguro lo ofrece a un costo menor o si lo paga de su bolsillo. <\/span><\/li>\n<\/ul>\n<h3><b>Qu&eacute; significa esto para ti<\/b><\/h3>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">La aprobaci&oacute;n de Merilog ofrece una opci&oacute;n potencialmente de menor costo para los 8,4 millones de estadounidenses que dependen de la insulina para controlar la diabetes.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">&iexcl;Habla con tu m&eacute;dico o farmac&eacute;utico para ver si Merilog es adecuado para ti!<\/span><\/li>\n<\/ul>\n\n","protected":false},"excerpt":{"rendered":"<p>La Administraci&oacute;n de Alimentos y Medicamentos de los Estados Unidos (FDA) ha aprobado Merilog (insulina-aspart-szjj), a biosimilar a Novolog (insulina aspart). Esto significa que ahora tienes otra opci&oacute;n de insulina de acci&oacute;n r&aacute;pida para ayudarte a mantener tus niveles de glucosa en sangre bajo control a la hora de comer. &iquest;Qu&eacute; es Merilog? Merilog es [&hellip;]<\/p>\n","protected":false},"author":11,"featured_media":35982,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-35990","resources","type-resources","status-publish","has-post-thumbnail","hentry","content-categories-noticias","topics-comunidad","topics-insulina-y-medicamentos","diabetes-types-tipo-1","tags-insulina","tags-noticias"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>La FDA aprueba Merilog: una nueva opci\u00f3n de insulina de acci\u00f3n r\u00e1pida | Beyond Type 1<\/title>\n<meta name=\"description\" content=\"La FDA aprueba Merilog, un nuevo biosimilar de insulina de acci\u00f3n r\u00e1pida a Novolog, que ofrece una opci\u00f3n segura, eficaz y potencialmente asequible.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/beyondtype1.org\/es\/fda-aprueba-merilog-insulina-de-accion-rapida\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"La FDA aprueba Merilog: una nueva opci\u00f3n de insulina de acci\u00f3n r\u00e1pida | Beyond Type 1\" \/>\n<meta property=\"og:description\" content=\"La FDA aprueba Merilog, un nuevo biosimilar de insulina de acci\u00f3n r\u00e1pida a Novolog, que ofrece una opci\u00f3n segura, eficaz y potencialmente asequible.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/beyondtype1.org\/es\/fda-aprueba-merilog-insulina-de-accion-rapida\/\" \/>\n<meta property=\"og:site_name\" content=\"Beyond Type 1\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/beyondtype1\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-18T23:39:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/02\/BT1-BT2-INTL-BREAKING-NEWS-HEADER-THUMB-MARCH-2023_ENG-OPTION-2-1024x367.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"367\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@BeyondType1\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/beyondtype1.org\/es\/fda-aprueba-merilog-insulina-de-accion-rapida\/\",\"url\":\"https:\/\/beyondtype1.org\/es\/fda-aprueba-merilog-insulina-de-accion-rapida\/\",\"name\":\"La FDA aprueba Merilog: una nueva opci\u00f3n de insulina de acci\u00f3n r\u00e1pida | Beyond Type 1\",\"isPartOf\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/fda-aprueba-merilog-insulina-de-accion-rapida\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/fda-aprueba-merilog-insulina-de-accion-rapida\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/02\/BT1-BT2-INTL-BREAKING-NEWS-HEADER-THUMB-MARCH-2023_ENG-OPTION-2.png\",\"datePublished\":\"2025-02-18T23:37:32+00:00\",\"dateModified\":\"2025-02-18T23:39:57+00:00\",\"description\":\"La FDA aprueba Merilog, un nuevo biosimilar de insulina de acci\u00f3n r\u00e1pida a Novolog, que ofrece una opci\u00f3n segura, eficaz y potencialmente asequible.\",\"breadcrumb\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/fda-aprueba-merilog-insulina-de-accion-rapida\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/beyondtype1.org\/es\/fda-aprueba-merilog-insulina-de-accion-rapida\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/beyondtype1.org\/es\/fda-aprueba-merilog-insulina-de-accion-rapida\/#primaryimage\",\"url\":\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/02\/BT1-BT2-INTL-BREAKING-NEWS-HEADER-THUMB-MARCH-2023_ENG-OPTION-2.png\",\"contentUrl\":\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/02\/BT1-BT2-INTL-BREAKING-NEWS-HEADER-THUMB-MARCH-2023_ENG-OPTION-2.png\",\"width\":2048,\"height\":733,\"caption\":\"FDA Approves Merilog: A New Rapid-Acting Insulin Option\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/beyondtype1.org\/es\/fda-aprueba-merilog-insulina-de-accion-rapida\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/beyondtype1.org\/es\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"La FDA aprueba Merilog: una nueva opci\u00f3n de insulina de acci\u00f3n r\u00e1pida\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/beyondtype1.org\/es\/#website\",\"url\":\"https:\/\/beyondtype1.org\/es\/\",\"name\":\"Beyond Type 1\",\"description\":\"Beyond Type 1 is the largest diabetes org online, funding advocacy, education and cure research.\",\"publisher\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/beyondtype1.org\/es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/beyondtype1.org\/es\/#organization\",\"name\":\"Beyond Type 1\",\"url\":\"https:\/\/beyondtype1.org\/es\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/beyondtype1.org\/es\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/08\/header-logo.svg\",\"contentUrl\":\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/08\/header-logo.svg\",\"width\":56,\"height\":56,\"caption\":\"Beyond Type 1\"},\"image\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/beyondtype1\",\"https:\/\/x.com\/BeyondType1\",\"http:\/\/instagram.com\/BeyondType1\/\",\"https:\/\/www.youtube.com\/c\/BeyondType1\",\"https:\/\/www.tiktok.com\/@beyondtype1\",\"https:\/\/www.linkedin.com\/company\/beyond-type1\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"La FDA aprueba Merilog: una nueva opci\u00f3n de insulina de acci\u00f3n r\u00e1pida | Beyond Type 1","description":"La FDA aprueba Merilog, un nuevo biosimilar de insulina de acci\u00f3n r\u00e1pida a Novolog, que ofrece una opci\u00f3n segura, eficaz y potencialmente asequible.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/beyondtype1.org\/es\/fda-aprueba-merilog-insulina-de-accion-rapida\/","og_locale":"es_ES","og_type":"article","og_title":"La FDA aprueba Merilog: una nueva opci\u00f3n de insulina de acci\u00f3n r\u00e1pida | Beyond Type 1","og_description":"La FDA aprueba Merilog, un nuevo biosimilar de insulina de acci\u00f3n r\u00e1pida a Novolog, que ofrece una opci\u00f3n segura, eficaz y potencialmente asequible.","og_url":"https:\/\/beyondtype1.org\/es\/fda-aprueba-merilog-insulina-de-accion-rapida\/","og_site_name":"Beyond Type 1","article_publisher":"https:\/\/www.facebook.com\/beyondtype1","article_modified_time":"2025-02-18T23:39:57+00:00","og_image":[{"width":1024,"height":367,"url":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/02\/BT1-BT2-INTL-BREAKING-NEWS-HEADER-THUMB-MARCH-2023_ENG-OPTION-2-1024x367.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@BeyondType1","twitter_misc":{"Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/beyondtype1.org\/es\/fda-aprueba-merilog-insulina-de-accion-rapida\/","url":"https:\/\/beyondtype1.org\/es\/fda-aprueba-merilog-insulina-de-accion-rapida\/","name":"La FDA aprueba Merilog: una nueva opci\u00f3n de insulina de acci\u00f3n r\u00e1pida | Beyond Type 1","isPartOf":{"@id":"https:\/\/beyondtype1.org\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/beyondtype1.org\/es\/fda-aprueba-merilog-insulina-de-accion-rapida\/#primaryimage"},"image":{"@id":"https:\/\/beyondtype1.org\/es\/fda-aprueba-merilog-insulina-de-accion-rapida\/#primaryimage"},"thumbnailUrl":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/02\/BT1-BT2-INTL-BREAKING-NEWS-HEADER-THUMB-MARCH-2023_ENG-OPTION-2.png","datePublished":"2025-02-18T23:37:32+00:00","dateModified":"2025-02-18T23:39:57+00:00","description":"La FDA aprueba Merilog, un nuevo biosimilar de insulina de acci\u00f3n r\u00e1pida a Novolog, que ofrece una opci\u00f3n segura, eficaz y potencialmente asequible.","breadcrumb":{"@id":"https:\/\/beyondtype1.org\/es\/fda-aprueba-merilog-insulina-de-accion-rapida\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/beyondtype1.org\/es\/fda-aprueba-merilog-insulina-de-accion-rapida\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/beyondtype1.org\/es\/fda-aprueba-merilog-insulina-de-accion-rapida\/#primaryimage","url":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/02\/BT1-BT2-INTL-BREAKING-NEWS-HEADER-THUMB-MARCH-2023_ENG-OPTION-2.png","contentUrl":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/02\/BT1-BT2-INTL-BREAKING-NEWS-HEADER-THUMB-MARCH-2023_ENG-OPTION-2.png","width":2048,"height":733,"caption":"FDA Approves Merilog: A New Rapid-Acting Insulin Option"},{"@type":"BreadcrumbList","@id":"https:\/\/beyondtype1.org\/es\/fda-aprueba-merilog-insulina-de-accion-rapida\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/beyondtype1.org\/es\/"},{"@type":"ListItem","position":2,"name":"La FDA aprueba Merilog: una nueva opci\u00f3n de insulina de acci\u00f3n r\u00e1pida"}]},{"@type":"WebSite","@id":"https:\/\/beyondtype1.org\/es\/#website","url":"https:\/\/beyondtype1.org\/es\/","name":"Beyond Type 1","description":"Beyond Type 1 is the largest diabetes org online, funding advocacy, education and cure research.","publisher":{"@id":"https:\/\/beyondtype1.org\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/beyondtype1.org\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/beyondtype1.org\/es\/#organization","name":"Beyond Type 1","url":"https:\/\/beyondtype1.org\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/beyondtype1.org\/es\/#\/schema\/logo\/image\/","url":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/08\/header-logo.svg","contentUrl":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/08\/header-logo.svg","width":56,"height":56,"caption":"Beyond Type 1"},"image":{"@id":"https:\/\/beyondtype1.org\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/beyondtype1","https:\/\/x.com\/BeyondType1","http:\/\/instagram.com\/BeyondType1\/","https:\/\/www.youtube.com\/c\/BeyondType1","https:\/\/www.tiktok.com\/@beyondtype1","https:\/\/www.linkedin.com\/company\/beyond-type1\/"]}]}},"_links":{"self":[{"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/resources\/35990","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/resources"}],"about":[{"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/types\/resources"}],"author":[{"embeddable":true,"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/comments?post=35990"}],"version-history":[{"count":0,"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/resources\/35990\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/media\/35982"}],"wp:attachment":[{"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/media?parent=35990"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}